HeLa y las CÉLULAS INMORTALES | 8 de febrero

HeLa y las CÉLULAS INMORTALES | 8 de febrero

Assessment

Interactive Video

Biology

9th - 10th Grade

Hard

Created by

Quizizz Content

FREE Resource

The transcript discusses the origin and significance of HeLa cells, the first immortal human cell line derived from Henrietta Lacks, who suffered from cervical cancer. Before 1951, growing human cells was challenging as they couldn't survive long. However, HeLa cells, discovered in 1951, overcame these challenges due to their ability to divide indefinitely, a trait of cancer cells. These cells have been pivotal in medical research, contributing to the development of the polio vaccine and being the first human cells cloned. HeLa cells have been mass-produced and used in various research areas, including cancer, AIDS, and toxicology, leading to over 80,000 scientific articles and 11,000 patents.

Read more

5 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What was the main challenge in growing human cells before the discovery of HeLa cells?

Contamination issues

High cost of cultivation

Inability to reproduce indefinitely

Lack of proper nutrients

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

How did HeLa cells contribute to the development of the polio vaccine?

By providing a model for virus replication

By being the first cells to be cloned

By offering a resilient cell line for testing

By being resistant to polio virus

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What characteristic of HeLa cells made them suitable for cloning?

Their resistance to viruses

Their large size

Their ability to change shape

Their unlimited reproductive capacity

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

In which areas of research have HeLa cells been extensively used?

Climate change studies

Agricultural development

Space exploration

Cancer and AIDS research

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Approximately how many scientific articles have been published related to HeLa cell research?

50,000

80,000

100,000

10,000